blue digital circular waveforms

Press Releases

March 13, 2023

iCAD Announces Leadership Transition

Stacey Stevens Resigns as President and CEO and as a Member of the Board Dana Brown Named President and CEO, remains Chairman of the Board NASHUA, N.H. – March 13, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced…

March 1, 2023

New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists’ Efficiency and Accuracy

Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools showcased at ECR 2023   NASHUA, N.H. – March 1, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new real-world clinical evidence to…

February 9, 2023

iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

NASHUA, N.H., February 9, 2023 — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 14-16, 2023 in Snowbird, UT.   Stacey…

January 23, 2023

iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI

Daniel Shea appointed as interim Chief Financial Officer   William Keyes hired as Senior Vice President, US Commercial Sales, AI   NASHUA, N.H. – January 23, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors…

January 11, 2023

iCAD Announces Board of Directors Transition

Dana Brown named Executive Chair of the Board   NASHUA, N.H. – January 11, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the appointment of Dana Brown as Executive Chair of the Board of Directors. Ms. Brown has been a…

December 8, 2022

iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar

Solis Mammography’s Chief Medical Officer Chirag Parghi, MD, to share clinical experience and real-world case studies demonstrating clinical value of ProFound AI   NASHUA, N.H. – December 5, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Solis Mammography, the…

November 28, 2022

iCAD and Google Health Ink Strategic Development and Commercialization Agreement

Google Health AI and Cloud technology to be integrated into iCAD’s portfolio with potential to elevate performance and expand access to millions of women worldwide   Agreement marks Google Health’s first partnership with a mammography AI vendor   NASHUA, N.H. – November 28, 2022 – iCAD, Inc. (NASDAQ: ICAD), a…

November 21, 2022

Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection

Study affirms utility of ProFound AI’s Case Scores in improving cancer detection   Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools showcased at largest medical imaging forum in the world   NASHUA, N.H. – November 21, 2022 – iCAD, Inc. (NASDAQ: ICAD), a…

November 15, 2022

iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference

NASHUA, N.H. – November 15, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, Chief Executive Officer, will participate at the 13th Annual Craig-Hallum Alpha Select Conference on Thursday, November 17th. The conference will be held…

November 14, 2022

iCAD to Present at HLTH 2022 With Google

Google invites iCAD’s President and CEO, Stacey Stevens, to be a featured speaker in the Google Health Theater Room on Tuesday, November 15   NASHUA, N.H. – November 14, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced iCAD…